During the past decade, Novum Pharmaceutical Research Services conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Novum Pharmaceutical Research Services" #1 sponsor was "Teva Pharmaceuticals USA" with 24 trials, followed by "Roxane Laboratories" with 17 trials sponsored, "Ranbaxy Laboratories Limited" with 10 trials sponsored, "Dr. Reddy's Laboratories Limited" with 4 trials sponsored and "Actavis Inc." with 4 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Novum Pharmaceutical Research Services" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Novum Pharmaceutical Research Services" are "Healthy" (41 trials), "Dry Mouth" (2 trials), "Essential Hypertension" (2 trials), "Inflammation" (2 trials) and "Seasonal Allergic Rhinitis" (2 trials). Many other conditions were trialed in "Novum Pharmaceutical Research Services" in a lesser frequency.

Most popular intervention types in "Novum Pharmaceutical Research Services" are "Drug" (65 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AMARYL® 4 mg Tablets" (2 trials), "AMBIEN® 10 mg tablets" (2 trials), "CIPRO®XR" (2 trials) and "Cefdinir for oral suspension 250 mg/5mL" (2 trials). Other intervention names were less common.

The vast majority of trials in "Novum Pharmaceutical Research Services" are 55 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Novum Pharmaceutical Research Services". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Novum Pharmaceutical Research Services, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Novum Pharmaceutical Research Services, 40 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 21 trials that are defined as “Not Applicable".